Sodium (S)-2-amino-3-(4-hydroxyphenyl)propanoate, 95.0%, 500g

2,2'-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,1'-biphenyl>98.0%(GC)(T)1g

ETHYL 5-AMINO-1H-IMIDAZOLE-4-CARBOXYLATE, 95.0%, 25g

Cyanuric Acid>98.0%(GC)(T)500g

Potassium (2,4-difluorophenyl)trifluoroborate, 97.0%, 5g

(4-(Dimethylamino)pyridin-2-yl)methanol, 95%, 2g

(S)-2-(N-Fmoc-N-methyl-amino)-3-cyclopropylpropanoic acid, 98%, 1g

(R)-2-(4-Fluorophenyl)-2-hydroxyacetic acid, 98%, 1g

2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS]>98.0%(HPLC)(T)1g

beta-Butyrolactone, 98%, 5g

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-fluorophenyl)propanoic acid, 97%, 10g

N-(4-Fluorophenyl)-3-oxo-butyramide, 100mg

Ethyl 1-cyanocyclobutanecarboxylate, 95.0%, 100g